Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Xentria

    Client Virtual Booth

    XENTRIA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Xentria
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8700 W Bryn Mawr Ave Ste 600S Chicago, IL
    Telephone
    Telephone
    +1 224-443-4615
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xentria.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xentria-inc/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Xentria’s XTMAB-16 Receives Orphan Drug Designation From EMA
    Xentria’s XTMAB-16 Receives Orphan Drug Designation From EMA

    https://www.businesswire.com/news/home/20231115747602/en

    BUSINESSWIRE
    15 Nov 2023
    Share Share
    Meitheal pays Xentria $45M for right to TNF drug in lung disease
    Meitheal pays Xentria $45M for right to TNF drug in lung disease

    https://www.fiercebiotech.com/biotech/meitheal-bets-there-still-life-tnf-inhibitors-paying-xentria-45m-rights-lung-disease

    Nick Paul Taylor FIERCE BIOTECH
    27 Jun 2023
    Share Share
    Xentria Announces Peer Reviewed Publication of Biosimulation Model
    Xentria Announces Peer Reviewed Publication of Biosimulation Model

    https://www.businesswire.com/news/home/20230321005189/en

    BUSINESSWIRE
    21 Mar 2023
    Share Share
    Xentria Appoints Lead Scientific Advisor and Chief Operating Officer
    Xentria Appoints Lead Scientific Advisor and Chief Operating Officer

    https://www.businesswire.com/news/home/20220804005139/en

    BUSINESSWIRE
    04 Aug 2022
    Share Share
    Xentria Announces Initial Findings Showing Novel Biologic XTMAB-16’s Potential
    Xentria Announces Initial Findings Showing Novel Biologic XTMAB-16’s Potential

    https://www.businesswire.com/news/home/20220623005200/en

    BUSINESSWIRE
    23 Jun 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search